Long-term Puberty Suppression for a Nonbinary Teenager.

Adolescent Anxiety / drug therapy Bioethical Issues Bone Density / drug effects Clinical Decision-Making / ethics Drug Administration Schedule Ethics, Medical Gender Dysphoria / drug therapy Hip Fractures / etiology Humans Informed Consent By Minors / ethics Parental Consent / ethics Personal Autonomy Puberty / drug effects Selective Estrogen Receptor Modulators / therapeutic use Sexual and Gender Minorities / psychology

Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
02 2020
Historique:
accepted: 28 05 2019
pubmed: 25 1 2020
medline: 17 4 2020
entrez: 25 1 2020
Statut: ppublish

Résumé

Many transgender and gender-diverse people have a gender identity that does not conform to the binary categories of male or female; they have a nonbinary gender. Some nonbinary individuals are most comfortable with an androgynous gender expression. For those who have not yet fully progressed through puberty, puberty suppression with gonadotrophin-releasing hormone agonists can support an androgynous appearance. Although such treatment is shown to ameliorate the gender dysphoria and serious mental health issues commonly seen in transgender and gender-diverse young people, long-term use of puberty-suppressing medications carries physical health risks and raises various ethical dilemmas. In this Ethics Rounds, we analyze a case that raised issues about prolonged pubertal suppression for a patient with a nonbinary gender.

Identifiants

DOI: 10.1542/peds.2019-1606 PMID: 31974217
pubmed: 31974217
pii: peds.2019-1606
doi: 10.1542/peds.2019-1606
pii:
doi:

Substances chimiques

Selective Estrogen Receptor Modulators 0

Types de publication

Case Reports Letter Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 by the American Academy of Pediatrics.

Déclaration de conflit d'intérêts

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

Auteurs

Ken C Pang (KC)

Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Department of Adolescent Medicine and.
Departments of Paediatrics and.
Psychiatry.

Lauren Notini (L)

Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Melbourne Law School, and.

Rosalind McDougall (R)

School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.

Lynn Gillam (L)

School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Children's Bioethics Centre, The Royal Children's Hospital, Melbourne, Victoria, Australia.

Julian Savulescu (J)

Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Uehiro Centre for Practical Bioethics, Oxford University, Oxford, United Kingdom.

Dominic Wilkinson (D)

Uehiro Centre for Practical Bioethics, Oxford University, Oxford, United Kingdom.

Beth A Clark (BA)

The University of British Columbia, Vancouver, Canada.

Johanna Olson-Kennedy (J)

University of Southern California, Los Angeles, California; and.

Michelle M Telfer (MM)

Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Department of Adolescent Medicine and.

John D Lantos (JD)

Bioethics Center, Children's Mercy Hospital, Kansas City, Missouri jlantos@cmh.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adolescent › Long-term Puberty Suppression for a Nonbinary Teenager.
questionsmedicales.fr › Comportement et mécanismes comportementaux › Émotions › Anxiété › Long-term Puberty Suppression for a Nonbinary Teenager.
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Éthique › Questions bioéthiques › Long-term Puberty Suppression for a Nonbinary Teenager.
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système locomoteur › Densité osseuse › Long-term Puberty Suppression for a Nonbinary Teenager.
questionsmedicales.fr › Diagnostic › Prise de décision clinique › Long-term Puberty Suppression for a Nonbinary Teenager.
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Calendrier d'administration des médicaments › Long-term Puberty Suppression for a Nonbinary Teenager.
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Éthique › Déontologie › Éthique clinique › Déontologie médicale › Long-term Puberty Suppression for a Nonbinary Teenager.
questionsmedicales.fr › Troubles mentaux › Dysfonctionnements sexuels psychogènes › Dysphorie de genre › Long-term Puberty Suppression for a Nonbinary Teenager.
questionsmedicales.fr › Plaies et blessures › Traumatismes de la jambe › Fractures du fémur › Fractures de la hanche › Long-term Puberty Suppression for a Nonbinary Teenager.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Long-term Puberty Suppression for a Nonbinary Teenager.
questionsmedicales.fr › Organisations et économie des soins de santé › Contrôle social formel › Jurisprudence › Consentement libre et éclairé › Consentement éclairé des mineurs › Long-term Puberty Suppression for a Nonbinary Teenager.
questionsmedicales.fr › Organisations et économie des soins de santé › Contrôle social formel › Jurisprudence › Consentement libre et éclairé › Consentement d'un tiers › Consentement parental › Long-term Puberty Suppression for a Nonbinary Teenager.
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Éthique › Éthique basée sur les principes › Autonomie personnelle › Long-term Puberty Suppression for a Nonbinary Teenager.
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Développement sexuel › Puberté › Long-term Puberty Suppression for a Nonbinary Teenager.
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Hormones, substituts d'hormones et antagonistes d'hormones › Antihormones › Modulateurs des récepteurs des oestrogènes › Modulateurs sélectifs des récepteurs des oestrogènes › Long-term Puberty Suppression for a Nonbinary Teenager.
questionsmedicales.fr › Personnes › Disparités en matière de santé, minorités et populations vulnérables › Minorités sexuelles › Long-term Puberty Suppression for a Nonbinary Teenager.